Growth promoting and metabolic activity of the human insulin analogue [Gly(A21),Arg(B31),Arg(B32)]insulin (HOE 901) in muscle cells

European Journal of Pharmacology

Volumn 320, Issue 2-3, 1997, Pages 259-265

  Bähr, Monika ^a   Kolter, Thomas ^a   Seipke, Gerhard ^b   Eckel, Jürgen ^a  

^a LEIBNIZ CENTER FOR DIABETES RESEARCH AT HEINRICH HEINE UNIVERSITY DÜSSELDORF   (Germany)

^b SANOFI   (France)

Author keywords

Cardiomyocyte; Insulin; Insulin analog; Insulin like growth factor receptor; Mitogenic activity

Indexed keywords

INSULIN DERIVATIVE; INSULIN GLARGINE; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DNA SYNTHESIS; DRUG ACTIVITY; DRUG RECEPTOR BINDING; GLUCOSE TRANSPORT; MITOGENESIS; MUSCLE CELL; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; CELL DIVISION; CELL LINE; DNA; GLUCOSE TRANSPORTER TYPE 4; HEART; HEART VENTRICLES; HUMANS; INSULIN; MALE; MONOSACCHARIDE TRANSPORT PROTEINS; MUSCLE PROTEINS; MYOCARDIUM; RATS; RATS, WISTAR; RECEPTOR, IGF TYPE 1;

EID: 0031565279     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(96)00903-X     Document Type: Article

References (35)

1. Berti, L., B. Bossenmaier, M. Kellerer, E. Seffer, G. Seipke and H. Häring, 1995, Comparison of the human insulin analogs HOE 901 and Asp(B10): characteristics of receptor binding, activation and tyrosine phosphorylation of different substrate proteins, Diabetologia 38 (Suppl. 1), A191 (Abstract).
2. Bornfeldt, K.E., R.A. Gidlöf, A. Wasteson, M. Lake, A. Skottner and H.J. Arnqvist, 1991, Binding and biological effects of insulin, insulin analogues and insulin-like growth factors in rat aortic smooth muscle cells. Comparison of maximal growth promoting activities, Diabetologia 34, 307.
3. Brange, J., U. Ribel, J.F. Hansen, G. Dodson, M.T. Hansen, S. Havelund, S.G. Melberg, F. Norris, K. Norris, L. Snel, A.R. Sorensen and H.O. Voigt, 1988, Monomeric insulins obtained by protein engineering and their medical implications, Nature 333, 679.
4. Brunetti, A., B.A. Maddux, K.Y. Wong and I.D. Goldfine, 1989, Muscle cell differentiation is associated with increased insulin receptor biosynthesis and messenger RNA levels, J. Clin. Invest. 83, 192.
5. Burke, G.T., S.Q. Hu, N. Ohta, G.P. Schwartz, L. Zong and P.G. Katsoyannis, 1990, Superactive insulins, Biochem. Biophys. Res. Commun. 173, 982.
6. De Meyts, P., C.T. Christoffersen, B. Urso, D. Ish-Shalom, N. Sacerdoti-Sierra, K. Drejer, L. Schäffer, R.M. Shymko and D. Naor, 1993, Insulin's potency as a mitogen is determined by the half-life of the insulin-receptor complex, Exp. Clin. Endocrinol. 101 (Suppl. 2), 22.
7. Dideriksen, L.H., L.N. Jorgensen and K. Drejer, 1992, Carcinogenic effect on female rats after 12 months administration of the insulin analogue B(10)Asp, Diabetes 41 (Suppl. 1), 143A (Abstract).
8. Drejer, K., V. Kruse, U.D. Larsen, P. Hougaard, S. Bjorn and S. Gammeltoft, 1991, Receptor binding and tyrosine kinase activation by insulin analogues with extreme affinities studied in human hepatoma HepG2 cells, Diabetes 40, 1488.
9. Eckel, J., G. Pandalis and H. Reinauer, 1983, Insulin action on glucose transport system in isolated cardiocytes from adult rat, Biochem. J. 212, 385.
10. Eckel, J., E. Gerlach-Eskuchen and H. Reinauer, 1990, G-protein mediated regulation of the insulin-responsive glucose transporter, Biochem. J. 272, 691.
11. Galloway, J.A., 1993, New directions in drug development: mixtures, analogues, and modeling, Diabetes Care 16 (Suppl. 3), 16.
12. Galloway, J.A. and R.E. Chance, 1994, Improving insulin therapy: achievements and challenges, Horm. Metab. Res. 26, 591.
13. Grau, U., 1985, Insulin-Arg2, a new retardation principle based on a natural proinsulin-derived processing intermediate, Diabetes Res. Clin. Pract. 1, 204 (Abstract).
14. Hilgenfeld, R., M. Dörschug, K. Geisen, H. Neubauer, R. Obermeier, G. Seipke and H. Berchtold, 1992, Controlling insulin bioavailability by crystal contact engineering, Diabetologia 35 (Suppl. 1), A 193 (Abstract).
15. Howey, D.C., R.R. Bowsher, R.L. Brunelle and J.R. Woodworth, 1994, [Lys(B28),Pro(B29)]-Human insulin: a rapidly absorbed analogue of human insulin, Diabetes 43, 396.
16. Jorgensen, S., A. Vaag, L. Langkjaer, P. Hougaard and J. Markussen, 1989, NovoSol Basal: pharmacokinetics of a novel soluble long acting insulin analogue, Br. Med. J. 299, 415.
17. Kimes, B.W. and B.L. Brandt, 1976, Properties of a clonal muscle cell line from rat heart, Exp. Cell Res. 98, 367.
18. Kjeldsen, T., A.S. Andersen, F.C. Wiberg, J.S. Rasmussen, L. Schäffer, P. Balschmidt, K. Bach-Moller and N.P.H. Moller, 1991, The ligand specificities of the insulin receptor and the insulin-like growth factor I receptor reside in different regions of a common binding site, Proc. Natl. Acad. Sci. USA 88, 4404.
19. Kolter, T., I. Uphues, A. Wichelhaus, H. Reinauer and J. Eckel, 1992, Contraction-induced translocation of the glucose transporter GLUT4 in isolated ventricular cardiomyocytes, Biochem. Biophys. Res. Commun. 189, 1207.
20. Lammers, R., A. Gray, J. Schlessinger and A. Ullrich, 1989, Differential signalling potential of insulin- and IGF-I-receptor cytoplasmic domains, EMBO J. 8, 1369.
21. Monti, L.D., R. Poma, A. Caumo, I. Stefani, A. Picardi, E.P. Sandoli, M. Zoltobrocki, P. Micossi and G. Pozza, 1992, Intravenous infusion of diarginylinsulin, an insulin analogue: effects on glucose turnover and lipid levels in insulin-treated type II diabetic patients, Metabolism 41, 540.
22. Pillemer, G., H. Lugasi-Evgi, G. Scharovski and D. Naor, 1992, Insulin dependence of murine lymphoid T-cell leukemia, Int. J. Cancer 50, 80.
23. Pullen, R.A., D.G. Lindsay, S.P. Wood, I.J. Tickle, T.L. Blundell, A. Wollmer, G. Krail, D. Brandenburg, H. Zahn, J. Gliemann and S. Gammeltoft, 1976, Receptor-binding region of insulin, Nature 259, 369.
24. Ribel, U., P. Hougaard, K. Drejer and A.R. Sorensen, 1990, Equivalent in vivo biological activity of insulin analogues and human insulin despite different in vitro potencies, Diabetes 39, 1033.
25. Robertson, D.A., B.M. Singh, P.J. Hale, I. Jensen and M. Nattrass, 1992, Metabolic effects of monomeric insulin analogues of different receptor affinity, Diabetic Med. 9, 240.
26. Russ, M. and J. Eckel, 1995, Insulin action on cardiac glucose transport: studies on the role of protein kianse C, Biochim. Biophys. Acta 1265, 73.
27. Seipke, G., K. Geisen, H.-P. Neubauer, C. Pittius, R. Roßkamp and D. Schwabe, 1992, New insulin preparations with prolonged action profiles: A21-modified arginine insulins, Diabetologia 35 (Suppl. 1), A 4 (Abstract).
28. Standaert, M.L., S. Schimmel and R.J. Pollet, 1984, The development of insulin receptors and responses in the differentiating non-fusing muscle cell line BC3H-1, J. Biol. Chem. 259, 2337.
29. Stout, R.W., 1990, Insulin and atheroma: 20-yr perspective, Diabetes Care 13, 631.
30. Straus, D.S., 1989, Regulation by insulin of cellular growth and proliferation: relationship to the insulin-like growth factors, in: Insulin Action, eds. B. Draznin, S. Melmed and D. LeRoith (A.R. Liss, New York) p. 143.
31. Talaulicar, M., B. Willms and R. Roßkamp, 1994, Efficacy of HOE 901 following subcutaneous injection for four days in type I diabetic subjects, Diabetologia 37 (Suppl. 1), A 169 (Abstract).
32. The DCCT Research Group, 1993, The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus, New Engl. J. Med. 329, 977.
33. Volund, A., J. Brange, K. Drejer, I. Jensen, J. Markussen, U. Ribel, A.R. Sorensen and J. Schlichtkrull, 1991, In vitro and in vivo potency of insulin analogues designed for clinical use, Diabetic Med. 8, 839.
34. Zeuzem, S., E. Stahl, E. Jungmann, M. Zoltobrocki, K. Schöffling and W.F. Caspary, 1990, In vitro activity of biosynthetic human diarginylinsulin, Diabetologia 33, 65.
35. Zhang, W., T.A. Gustafson, W.J. Rutter and J.D. Johnson, 1994, Positively charged side chains in the insulin-like growth factor-1 C- and D-regions determine receptor binding specificity, J. Biol. Chem. 269, 10609.